Handelsbanken Fonder AB boosted its stake in Danaher Corporation (NYSE:DHR – Free Report) by 10.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 289,223 shares of the conglomerate’s stock after acquiring an additional 28,425 shares during the period. Handelsbanken Fonder AB’s holdings in Danaher were worth $55,091,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Sivia Capital Partners LLC boosted its stake in shares of Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares during the last quarter. First Trust Advisors LP raised its stake in Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after buying an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC raised its stake in Danaher by 40.2% during the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after buying an additional 886 shares during the last quarter. Ieq Capital LLC lifted its holdings in Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after buying an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC lifted its holdings in Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after buying an additional 325 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.
Analyst Upgrades and Downgrades
DHR has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Wells Fargo & Company dropped their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Piper Sandler assumed coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price on the stock. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Finally, Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average target price of $228.91.
Danaher Stock Performance
Shares of DHR opened at $208.92 on Tuesday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a market cap of $146.87 billion, a PE ratio of 37.11, a P/E/G ratio of 2.55 and a beta of 0.78. The stock has a 50-day moving average of $191.24 and a 200-day moving average of $193.84. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.77 EPS. On average, equities research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
-pt-telekomunikasi-indonesia-tbk-logo-1200x675.png){kind=logo}
